What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His scientific interests lie mostly in Chemotherapy, Germ cell tumors, Surgery, Internal medicine and Cisplatin.
His studies in Chemotherapy integrate themes in fields like Regimen and Toxicity.
His Germ cell tumors study combines topics in areas such as Cancer, Chromosome, Chromosome 12, Pathology and Tumor suppressor gene.
His research in Internal medicine intersects with topics in Gastroenterology and Oncology.
His research investigates the connection between Oncology and topics such as Testicular cancer that intersect with issues in Disease.
His Cisplatin research incorporates themes from Cancer research, Endocrinology, Vinblastine, Apoptosis and Paclitaxel.
His most cited work include:
- Testicular Germ-Cell Cancer (755 citations)
- Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design (474 citations)
- Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors (266 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Germ cell tumors, Chemotherapy, Internal medicine, Surgery and Oncology.
George J. Bosl interconnects Cancer research, Teratoma, Pathology, Germ cell and Seminoma in the investigation of issues within Germ cell tumors.
His Chemotherapy research is multidisciplinary, incorporating elements of Regimen, Radiation therapy and Toxicity.
The Etoposide, Bleomycin and Disease research George J. Bosl does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
His Surgery research incorporates elements of Cancer and Urology.
His Oncology research includes themes of Salvage therapy, Clinical trial and Testicular cancer.
He most often published in these fields:
- Germ cell tumors (47.13%)
- Chemotherapy (38.85%)
- Internal medicine (36.62%)
What were the highlights of his more recent work (between 2012-2021)?
- Germ cell tumors (47.13%)
- Internal medicine (36.62%)
- Oncology (27.07%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Germ cell tumors, Internal medicine, Oncology, Retroperitoneal lymph node dissection and Chemotherapy.
His Germ cell tumors research is multidisciplinary, incorporating elements of Ifosfamide, Bleomycin, Teratoma and Cancer research.
His work deals with themes such as Incidence, Cisplatin, Etoposide, Regimen and Germ cell, which intersect with Oncology.
As part of his research on Retroperitoneal lymph node dissection, studies on Surgery and Cancer are part of the effort.
His Surgery study incorporates themes from Pathological and Urology.
George J. Bosl studied Chemotherapy and Lymph that intersect with Adjuvant therapy.
Between 2012 and 2021, his most popular works were:
- Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm (29 citations)
- Interrogation of a Context‐Specific Transcription Factor Network Identifies Novel Regulators of Pluripotency (29 citations)
- Optimal Management of Clinical Stage I Testis Cancer: One Size Does Not Fit All (26 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
George J. Bosl spends much of his time researching Germ cell tumors, Internal medicine, Cancer, Retroperitoneal lymph node dissection and Oncology.
George J. Bosl has researched Germ cell tumors in several fields, including Cisplatin, Gene mapping, Comparative genomic hybridization, Seminoma and Gene prediction.
His research on Cisplatin concerns the broader Chemotherapy.
Retroperitoneal lymph node dissection is a subfield of Surgery that he investigates.
His Surgery study often links to related topics such as Urology.
His study focuses on the intersection of Oncology and fields such as Teratoma with connections in the field of Survival rate.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
